Investing

Apogee Therapeutics : APGE

APGE

Stock Data

$132.88

$0.33 (0.25%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Apogee Therapeutics Inc is a biotechnology firm based in Waltham, Massachusetts, focusing on creating innovative treatments for atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and other related conditions. The company is known for its development of groundbreaking monoclonal antibodies, including APG777 for AD and APG808 for COPD, aiming to improve patients' lives through advanced biologics. Founded in 2022, Apogee Therapeutics is at the forefront of addressing unmet medical needs in inflammatory and immunology indications.

All Apogee Therapeutics Articles

1 Article

Lee Jackson | 14 minutes ago

Here Are Wednesday’s Best Wall Street Analyst Research Calls: Devon Energy, Flowserve, Klaviyo, Macerich, Merck, Nucor, Take-Two Interactive Software, Twilio, and More

  Pre-Market Stock Futures: Futures are trading higher this morning, but if you’ve ever heard the old saying, “when the…